We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$505M
AUM Growth
+$21.2M
Cap. Flow
+$5.15M
Cap. Flow %
1.02%
Top 10 Hldgs %
35.51%
Holding
232
New
2
Increased
25
Reduced
45
Closed
100

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.2M
2
UAA icon
Under Armour
UAA
+$6.05M
3
ALKS icon
Alkermes
ALKS
+$1.38M
4
APTV icon
Aptiv
APTV
+$568K
5
CHKP icon
Check Point Software Technologies
CHKP
+$421K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$3.12M
2
GILD icon
Gilead Sciences
GILD
+$2.54M
3
SLB icon
SLB Ltd
SLB
+$733K
4
ENOV icon
Enovis
ENOV
+$503K
5
AMAT icon
Applied Materials
AMAT
+$467K

Sector Composition

Rank Sector Weight
1 Healthcare 19.81%
2 Financials 19.4%
3 Technology 18.33%
4 Consumer Staples 11.07%
5 Consumer Discretionary 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLZ icon
26
Mondelez International
MDLZ
$79.9B
$8.37M 1.66%
193,880
+2,275
+1% +$103K
AFL icon
27
Aflac
AFL
$62.6B
$7.8M 1.54%
200,970
– –
GS icon
28
Goldman Sachs
GS
$303B
$7.51M 1.49%
33,867
+560
+2% +$124K
CVX icon
29
Chevron
CVX
$366B
$7.3M 1.44%
69,966
-2,240
-3% -$237K
ENOV icon
30
Enovis
ENOV
$1.53B
$7.03M 1.39%
103,709
-7,378
-7% -$503K
ALKS icon
31
Alkermes
ALKS
$8.25B
$6.85M 1.35%
118,100
+23,700
+25% +$1.38M
UAA icon
32
Under Armour
UAA
$2.6B
$6.47M 1.28%
+297,180
New +$6.05M
ETN icon
33
Eaton
ETN
$174B
$6.34M 1.25%
81,480
+3,050
+4% +$232K
SLB icon
34
SLB Ltd
SLB
$75B
$6.16M 1.22%
93,611
-10,235
-10% -$733K
GOOG icon
35
Alphabet (Google) Class C
GOOG
$4.32T
$6M 1.19%
131,940
– –
EW icon
36
Edwards Lifesciences
EW
$51.7B
$5.58M 1.1%
141,600
+1,800
+1% +$65.7K
JPM icon
37
JPMorgan Chase
JPM
$950B
$5.54M 1.1%
60,557
– –
CSCO icon
38
Cisco
CSCO
$479B
$5.05M 1%
161,271
+5,900
+4% +$192K
AMAT icon
39
Applied Materials
AMAT
$428B
$4.93M 0.98%
119,320
-11,000
-8% -$467K
PG icon
40
Procter & Gamble
PG
$339B
$3.42M 0.68%
39,305
-2,378
-6% -$210K
VRTX icon
41
Vertex Pharmaceuticals
VRTX
$126B
$2.72M 0.54%
21,087
– –
MMM icon
42
3M
MMM
$94.3B
$2.25M 0.45%
12,943
-2,775
-18% -$464K
GILD icon
43
Gilead Sciences
GILD
$165B
$2.1M 0.41%
29,605
-38,150
-56% -$2.54M
GE icon
44
GE Aerospace
GE
$384B
$2.06M 0.41%
15,921
-208
-1% -$28.5K
ABBV icon
45
AbbVie
ABBV
$435B
$1.94M 0.38%
26,695
– –
XOM icon
46
ExxonMobil
XOM
$634B
$1.53M 0.3%
18,918
-200
-1% -$16.4K
ALB icon
47
Albemarle
ALB
$15.5B
$1.47M 0.29%
13,958
-400
-3% -$43.5K
RDS.A
48
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.47M 0.29%
27,574
-471
-2% -$25K
CYS.PRB
49
DELISTED
CYS Investments, Inc.
CYS.PRB
$1.43M 0.28%
58,650
+6,300
+12% +$152K
WFC.PRL icon
50
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.37M 0.27%
1,045
– –
1
2
3 4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $360M AUM 19.98% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Kelly Lawrence W & Associates held 232 positions worth $505M, up 4.4% from $484M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates's Q2 2017 filing shows 2 new, 25 increased, 45 reduced and 100 closed positions. Its largest new stake was Under Armour: 297,180 shares worth $6.47M. The largest sale was IBM, an estimated $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • Kelly Lawrence W & Associates's largest Q2 2017 buy was Under Armour: 297,180 shares worth $6.47M.
  • Kelly Lawrence W & Associates added most to Allergan plc in Q2 2017, an estimated $6.2M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2017 reduction was IBM, cutting an estimated $3.12M.
  • Kelly Lawrence W & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $293K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $505M portfolio in Q2 2017.
  • Kelly Lawrence W & Associates opened 2 new positions and closed 100 in Q2 2017.
  • Kelly Lawrence W & Associates's portfolio value rose 4.4% quarter-over-quarter to $505M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2017, filed 1 Aug 2017.